Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
78
datasets available to search
ShareScore release 0.9.0
Dataset results
78 results for “HCC recurrence”
A Study of LioCyx in Patient With Recurrent HBV-related HCC Post Liver Transplantation
ClinicalTrials.gov study NCT03634683. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Tenofovir Alafenamide(TAF) Reduces the Risk of Hepatocellular Carcinoma(HCC) Recurrence
ClinicalTrials.gov study NCT04290936. IPD Sharing: NO. Countries: 1. Publications: 0.
Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection
ClinicalTrials.gov study NCT06454578. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT01198704. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC
ClinicalTrials.gov study NCT06609876. IPD Sharing: NO. Countries: 1. Publications: 0.
A Multicenter Study of Anlotinib in Hepatocellular Carcinoma (HCC) Patients at High Risk of Post Surgery Recurrence
ClinicalTrials.gov study NCT03945799. IPD Sharing: YES. Countries: 1. Publications: 0.
Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT01318200. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC
ClinicalTrials.gov study NCT07350824. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection
ClinicalTrials.gov study NCT05489289. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of TACE Combined With Lenvatinib to Prevent Postoperative Recurrence in Patients With MVI Positive HCC
ClinicalTrials.gov study NCT04911959. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TQB2450 Plus Anlotinib as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Resection
ClinicalTrials.gov study NCT05111366. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Title of Manuscript: Development and Internal-external Validation of a Comprehensive Model for Predicting Risk of Post-RFA Recurrence in HCC Patients
ClinicalTrials.gov study NCT06577272. IPD Sharing: Not stated. Countries: 1. Publications: 0.
WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical Therapy
ClinicalTrials.gov study NCT07077369. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Iparomlimab and Tuvonralimab Injection (QL1706) Combined With Bevacizumab for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma (HCC) With High Risk of Recurrence
ClinicalTrials.gov study NCT06958484. IPD Sharing: NO. Countries: 0. Publications: 0.
Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence
ClinicalTrials.gov study NCT05545124. IPD Sharing: Not stated. Countries: 0. Publications: 0.
DAA in the Risk of Recurrence After Curative Treatment of HCC
ClinicalTrials.gov study NCT02959359. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT Patients
ClinicalTrials.gov study NCT02813096. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Identification of recurrence related microRNAs from bone marrow in hepatocellular carcinoma (HCC) patients
GEO Series GSE71762. Homo sapiens. 28 samples. Type: Non-coding RNA profiling by array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.